Rui Wan Selected Research

Angiomyolipoma

1/2020

Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Wan Research Topics

Disease

22	Neoplasms (Cancer) 03/2024 - 01/2017
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2017
7	Lung Neoplasms (Lung Cancer) 10/2023 - 08/2017
4	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2017
4	Disease Progression 01/2023 - 10/2020
3	Adenocarcinoma of Lung 01/2024 - 01/2018
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 01/2019
2	Malignant Mesothelioma 04/2024 - 01/2023
2	Type I Syndactyly 02/2014 - 01/2014
1	Pre-Eclampsia (Preeclampsia) 01/2024
1	Frailty 01/2024
1	Sarcopenia 01/2024
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024
1	Triple Negative Breast Neoplasms 11/2023
1	Melanoma (Melanoma, Malignant) 10/2023
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 07/2023
1	Tics (Tic) 05/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 11/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022
1	Morbid Obesity 06/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022
1	Carcinoma (Carcinomatosis) 10/2020
1	Exanthema (Rash) 10/2020
1	Tertiary Lymphoid Structures 10/2020
1	Angiomyolipoma 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Hand-Foot Syndrome 01/2019
1	Fatigue 01/2019
1	Microsatellite Instability 11/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
7	Immune Checkpoint InhibitorsIBA 03/2024 - 11/2018
6	LigandsIBA 11/2022 - 11/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2024 - 01/2017
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 01/2017
2	apatinibIBA 10/2022 - 01/2019
2	Circulating Tumor DNAIBA 01/2022 - 01/2017
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2021 - 01/2020
2	PlatinumIBA 01/2021 - 01/2019
2	SimazineIBA 02/2014 - 01/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2024
1	Metformin (Glucophage)FDA LinkGeneric 01/2024
1	BerberineIBA 01/2024
1	baicaleinIBA 01/2024
1	LuteolinIBA 01/2024
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024
1	Interleukin-12 (IL 12)IBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 01/2024
1	CytokinesIBA 01/2024
1	Macrophage Colony-Stimulating FactorIBA 01/2024
1	InterferonsIBA 01/2024
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2024
1	Deubiquitinating EnzymesIBA 11/2023
1	Antiviral Agents (Antivirals)IBA 11/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	Uric Acid (Urate)IBA 01/2023
1	ChemokinesIBA 11/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2022
1	Histone Deacetylase InhibitorsIBA 11/2022
1	Sucrose (Saccharose)IBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	venetoclaxIBA 10/2022
1	Melanocortin Receptors (Melanocortin Receptor)IBA 06/2022
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 06/2022
1	TabletsIBA 01/2022
1	AndrogensIBA 01/2022
1	Beclin-1IBA 01/2022
1	icotinibIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Bevacizumab (Avastin)FDA Link 12/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	tyrosine receptor (receptor, tyrosine)IBA 12/2020
1	EphrinsIBA 12/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020
1	AntibodiesIBA 10/2020
1	Amylases FDA Link 10/2020
1	toripalimabIBA 10/2020
1	B7-H1 AntigenIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Everolimus FDA Link 01/2020
1	BilirubinIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	TransglutaminasesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Death Domain ReceptorsIBA 11/2018

Therapy/Procedure

15	Therapeutics 04/2024 - 01/2017
12	Immunotherapy 03/2024 - 01/2020
8	Drug Therapy (Chemotherapy) 05/2023 - 08/2017
1	Salvage Therapy 04/2024
1	Filtering Surgery 07/2023
1	Phacoemulsification 07/2023
1	Adjuvant Chemotherapy 01/2021